It is a once-monthly, self-administered injection. Patients typically use a single-dose SureClick autoinjector or a prefilled syringe to inject the medication under the skin of the abdomen, thigh, or upper arm.
One of the greatest challenges in ALS is the diagnostic delay, which can average one year from symptom onset. Recent research focuses on fluid and neurophysiological biomarkers. amoytoge new